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In a  small  percentage of patients with  systemic lupus erythematosus  (SLE), 1 an 
autoantibody has been demonstrated that is reactive with a  nuclear antigen present 
in proliferating cells (PCNA)  (1). The nuclear antigen was not detected by immuno- 
fluorescence in renal tubular or glomerular cells nor in hepatic parenchymal cells, but 
was  detected  in  certain  unidentified  cells  in  the  interstitial  tissues  of these  organs. 
Normal peripheral blood lymphocytes did not contain detectable amounts of PCNA, 
but it was present in some lymphocytes in lymph node follicles, spleen, and thymus. 
After mitogen-induced  blast  transformation,  peripheral  blood  lymphocytes became 
positive for PCNA,  demonstrable as nuclear staining in the blast-transformed cells. 
Continuous  tissue culture cell lines of different species such as WiL-2,  Hep-2, baby 
hamster kidney walls, and Ehrlich ascites tumor cells were positive for PCNA. 
The reactive nuclear antigen was extractable from tissue culture cells with physio- 
logical saline, and the solubilized PCNA formed precipitin  lines with autoantibody 
that were immunologically distinct from previously identified autoantibodies, such as 
Sm antigen, nuclear RNP, and the SS-A/Ro and SS-B/La antigen-antibody systems 
(2).  In  previous  studies,  immunofluorescence  demonstrated  a  speckled  pattern  of 
nucleoplasmic staining. 
Because of the apparent association of PCNA with proliferation and blast transfor- 
mation,  we  have  attempted  to  determine  more  precisely  the  time  relationship  of 
PCNA  to  DNA,  RNA,  and  protein  synthetic  events  in  the  cell  cycle.  In  both 
continuously  proliferating  and  blast-transformed cells,  there  appears  to  be a  close 
relationship with a phase preceding active DNA synthesis. In addition, PCNA appears 
in the nucleolus at this time, a  phenomenon not previously recognized. 
Materials and Methods 
Preparation of Specific Anti-PCNA  Sera.  Two anti-PCNA sera (MN and EB) obtained from 
patients with SLE were used. In addition to anti-PCNA, these sera contained autoantibodies to 
other nuclear antigens, including double-stranded DNA, DNA-histone, and Sm (Table I). In 
serum MN,  antibody to  PCNA was  present  in  highest  titer,  and  at  the serum dilution  of 
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t Abbreviations used in this paper: FITC, fluorescein isothiocyanate; PBS, phosphate-buffered saline; PHA, 
phytohemagglutinin; PCNA,  proliferating cell nuclear antigen;  RNP,  ribonucleoprotein; Scl-70,  sclero- 
derma-70 antigen; SLE, systemic lupus erythematosus; SS-A, Sj6gren's syndrome-A antigen; SS-B, SjlJgren's 
syndrome-B antigen, 
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TABLE  I 
Characteristics ofSera  Contaimng Antibody to PCNA 
Antibodies to 
Serum 
DNA-His- 
PCNA  DS-DNA*  Sm 
tone 
MN  +  +  +  - 
EB  +  -  -  + 
*  Double-strand-DNA. 
1:1,024,  this  serum  was  monospecific  for  PCNA  as  demonstrated  by  immunofluorescence. 
However, insufficient quantities of this serum were available, and  it was used to confirm the 
observations  made with  serum  EB, which  was  available in larger quantities.  Serum  EB was 
rendered operationally monospecific for PCNA in the following manner. 
It  was  previously  observed  that  differentiated  tissues  such  as  rabbit  kidney  contained 
negligible amounts of PCNA (1). The small amounts present were probably in the unidentified 
cells scattered  in the interstitium.  This  tissue was  therefore  used as a  source of antigen(s)  to 
remove all autoantibodies except anti-PCNA from serum EB (1).  Rabbit kidney was homoge- 
nized with a  Potter homogenizer in 0.15 M  NaC1  (1 g rabbit  kidney/4 ml 0.15 M  NaCI), and 
the suspension was sonicated for 6 ×  15 second cycles at maximum output with a  model W185 
sonicator (Heat Systems-Ultrasonics, Plainview, N. Y.). The sonicate was stirred for 4 h at 4°C 
and centrifuged at 3,500 g for 30 min. The supernatant  contained -60 mg protein/ml and was 
the source material  for making solid phase immunoadsorbant  after the method of Avrameas 
and Ternynck  (3).  4 m! rabbit  kidney extract was mixed with 4 ml of bovine serum albumin 
(60 mg/ml), the latter being used as nonspecific protein carrier. To this mixture, 0.8 ml of 2 M 
acetate buffer, pH 5, was added, after which 2 ml of 2.5% glutaraldehyde was added dropwise 
to this mixture. The reaction mixture was allowed to stand for 3 h at room temperature without 
stirring. After the gel formed, it was homogenized with a  Potter homogenizer and dispersed in 
50 ml of 0.1  M  phosphate buffer, pH  7.4.  After centrifugation, the immunoadsorbent  gel was 
washed repeatedly with phosphate buffer until the OD 280 nm of the supernatant  was <0.050. 
The gel was then rehomogenized, dispersed in 50 ml of 0.2 M  HCl-glycine, pH 2.8, and stirred 
for  15  min at  room  temperature.  The  gel was  subsequently  neutralized  with  1 M  K2HPO4, 
centrifuged and dispersed in  10 ml of 0.1 M  lysine, and incubated overnight at 4°C. For use as 
immunoadsorbant,  the gel was washed in phosphate-buffered saline (PBS)  (0.15 M  NaC1, 0.01 
M  phosphate,  pH  7.4)  and  resuspended  in PBS containing 0.01%  sodium azide.  1 ml of anti- 
PCNA serum (EB) was diluted  1:10 with PBS, added to 30 ml of packed gel, and incubated for 
1 h at room temperature and for 24 h at 4°C. After this incubation, the mixture was centrifuged 
at 3,500 g  for 30 rain, the supernatant  recovered, and concentrated  to the starting volume of 
anti-PCNA  serum  with  a  Minicon  B125  concentrator  (Amicon Co.,  Bedford,  Mass.).  In  the 
absorbed serum  (EBa), autoantibodies  to Sm antigen were removed, but  anti-PCNA was still 
present  (see Results). 
An  extract  of WiL-2 cells, a  line of continuously  growing human  B  diploid  lymphocytes, 
were used as the source for PCNA antigen (4). The extraction of antigens from WiL-2 cells has 
been described  (5).  Briefly, cells in the log phase of growth were harvested and sonicated in a 
buffer containing 0.25 M  sucrose, 4 mM CaC12,  and  10 mM PO4, pH 6.2. The extract obtained 
from this  sonication contained  PCNA, as  well as other soluble nuclear antigens.  The WiL-2 
extract  was  used  as  the source  of antigen  in  double  diffusion  to  identify  precipitating  anti- 
PCNA antibody. 
Imrnunodiffusion and Immunofluorescent Methods.  A  double diffusion method was used to dem- 
onstrate  precipitating  antibodies  to  PCNA  and  other  soluble  nuclear  antigens  (6).  In  our 
laboratory, reference sera have been available for the identification of precipitating antibodies 
to  double-strand  DNA,  DNA-histone,  Sm  antigen,  and  other  nonhistone  nuclear  antigens. 
These  reference sera  were  placed  in  wells next  to  anti-PCNA  sera  to  determine  identity  or 
nonidentity of precipitin lines. The reactions were allowed to proceed at room temperature for 
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Indirect immunofluorescence was used with WiL-2 cell or human  peripheral blood lympho- 
cyte  preparations.  Cytocentrifugation  spreads  of  these  cells  were  prepared  from  a  0.1-ml 
suspension  containing  1.5 ×  106 cells/m1. The cell spreads were fixed in acetone for 10 min at 
room temperature.  It was found that cytocentrifuged cells were superior to cell smears because 
cytocentrifugation  produced  flat  preparations  of cells  with  more  even  distribution  of cell 
number.  The  conjugate  used  was  fluorescein  isothiocyanate  (FITC)-labeled  goat  anti-Cohn 
fraction II and had the following characteristics: FITC-132 p.g/ml; protein-14 m g/ml; unitage- 
8 U/ml; plateau endpoint-1:64 dilution (7).  This conjugate was diluted  1:20 in PBS for use in 
the indirect immunofluorescence technique. Stained slides were observed at a magnification of 
×  500 with an incident light microscope equipped with a 200-W Mercury light source, KPF 90 
exciter filter, and  K530 barrier filter. 
Synchronization of WiL-2 Cells and Determination of Phase of Cell Cycle. Two different methods of 
cell synchronization were used to study the distribution of PCNA in different phases of the cell 
cycle. In the first  method, WiL-2 cells were synchronized by starvation or density-dependent 
arrest  as  described  by  Lerner  and  Hodge  (8).  WiL-2 cells were  grown  in  Autopow  medium 
(Flow Laboratories, Inglewood, Calif.), supplemented with 2 mM glutamine, vitamins, nones- 
sential amino acids, sodium pyruvate,  100 U/ml penicillin,  100/xg/ml streptomycin, and  10% 
fetal bovine serum  (Flow Laboratories).  6-d-old cells were used as those arrested  in Go phase 
and  transferred  to  fresh  media  for synchronized  growth.  In  the  second  method,  a  modified 
double-thymidine block method was used  as described  by Galavazi and  Bootsma  (9).  WiL-2 
cells of 2-d-old cultures were treated  with  2  mM thymidine  (Sigma Chemical Co., St.  Louis, 
Mo.)  for  16  h.  The cells were washed  once in  fresh  medium  to remove thymidine  and  were 
grown in fresh complete medium. 6 h  later, 2 mM thymidine was added and incubated  for an 
additional  16 h. After the second thymidine treatment, the cells were washed and suspended in 
fresh complete medium. 
DNA synthesis and mitosis were studied at  2-h intervals to determine the phases of the cell 
cycle. For mitotic cell enumeration,  cells were treated with 0.2/lg/ml colcemid (Gibco, Grand 
Island  Biological  Co.,  Buffalo,  N.  Y.)  for  2  h,  washed  in  Hanks'  balanced  salt  solution 
centrifuged onto slides and stained with Giemsa. The percentage of mitotic cells was expressed 
as the mitotic index. For determining DNA synthesis,  [3H]thymidine  incorporation  of WiL-2 
cells was examined.  1-ml aliquots of cell suspension containing 2  ×  105 cells were pulsed with 
1 /LCi/ml  [3H]thymidine  (6.7  Ci/mM,  New  England  Nuclear,  Boston,  Mass.)  for  30  min, 
washed twice in PHS, pH 7.4, collected on Millipore filters (0.45 #m)  (Millipore Corp., Bedford, 
Mass.),  extracted  with  5%  trichloroacetic  acid,  dried,  and  counted  in  a  Beckman  liquid 
Fro.  1.  Immunodiffusion study  showing the reaction  of anti-PCNA test  serum  EB  (neat)  with 
WiL-2 extract before and after absorption with insolubilized  rabbit  kidney extract. Before absorp- 
tion, EB showed  two precipitin lines;  a weak line was identical to anti-Sm prototype serum;  the 
other  stronger  line was  identical  to  anti-PCNA  prototype  serum  (MN).  After  this  serum  was 
absorbed  with rabbit  kidney extract  (EBa),  it  showed  only one precipitin  line identical to MN. 
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scintillation counter  (Beckman  Instruments,  Fullerton, Calif.).  At  the same time, autoradiog- 
raphy was used to determine the percentage of cells in DNA  synthesis. 0.1-ml  aliquots of cell 
suspension (t.5 X  106 cells/ml) were centrifuged onto microscope slides. The smears were fixed 
in methanol-acetic acid mixture (3:1) for 10 min at room temperature. Slides were dipped into 
Kodak  NTB-2  nuclear  emulsion  (Eastman  Kodak  Co.,  Richester,  N.  Y.),  dried  at  room 
temperature  for  30  min,  and  incubated  for  a  week.  Then,  they  were  developed  in  Kodak 
TABLE II 
Characteristics of Anti-PCNA Serum (EB) before and after Absorption with 
Extract of Rabbit Kidney 
Precipitating  Endpoint of 
antibody to  staining on 
Mouse 
PCNA  Sm  kidney pa-  WiL-2 
renchymal  cells 
cells 
Before absorption  +  +  1:32  1:512 
After absorption*  +  -  0  1:64 
* 1 ml of the test serum EB was diluted l:10, then absorbed with 30 ml packed 
gel  volume  of insolubilized  saline-soluble extract  of rabbit  kidney.  The 
absorbed serum was concentrated back to original volume. 
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FIe,.  2.  Incorporation  of  [3H]tbymidine  ([aH]tbymidine  uptake,  H),  percentage  of cells 
incorporating [aH]thymidine by autoradiography ([aH]thymidine labeling index, ~  -  --m), and 
percentage of cells undergoing mitosis (mitotic index, •  .....  •)  in WiL-2 cells synchronized by the 
method of starvation are shown in A. During first 6-8 h, >90% of cells were in a  phase preceding 
DNA synthesis. After 8 h, cells began DNA synthesis and reached maximum DNA synthesis by 16 
18 h. By 22-24 h, the mitotic phase of the cell cycle had begun, preceded by a  fall in thymidine 
uptake. From these observations, the phases of WiL-2 cell synchronization were determined. In B, 
cells were taken every 2 h  and stained with anti-PCNA serum (EBa)  to determine relationship of 
nucleolar staining with cell cycle. The peak time for the appearance of PCNA in the nucleolus was 
at  t2 h, a period related to late G~ and early S. YOSHINARI  TAKASAKI, JAU-SHYONG  DENG,  AND  ENG  M.  TAN  1903 
FiG.  3.  Fluorescence  photomicrographs  of synchronized  WiL-2  cells  stained  with  anti-PCNA 
serum (EBa). WiL-2 cells were synchronized by the method of starvation as shown in Fig. 2 A. Fine 
speckled staining pattern was observed in Go phase (0-h cells) (A). Nucleolar staining appeared in 
addition to speckled nuclear staining in late GI and early S phase  (12-h cells) (B). In late S to G2 
phase (20-h cells) (C), most cells showed only speckled staining, and its intensity was stronger than 
in Go phase. In mitosis (D, arrows), radiating strands of staining could be observed within the region 
of chromosome condensation in addition to staining in areas peripheral to chromosome condensation 
(x 1,2oo). 
Developer 19, fixed in Kodak fixer and stained with Giemsa. The percentage of labeled cells on 
each cell smear was expressed as the labeling index. 
Preparation ofPhytohemagglutinin-stimulated Lymphocytes.  Human peripheral blood lymphocytes 
were separated by Ficoll-Hypaque density gradient centrifugation as described by B6yum (10). 
The preparations contained >90%  lymphocytes. Cells were suspended in RPMI  1640  (Flow 
Laboratories, Inglewood, Calif.), supplemented with 2 mM glutamine, vitamins, nonessential 
amino acids, sodium pyruvate,  100  U/ml penicillin, 100 p,g/ml streptomycin, and  15%  fetal 
bovine serum (Flow Laboratories, Inglewood, Calif.) to a concentration of I  ×  106/ml. 
The cell suspension was divided into two groups. One was cultured in the presence of 30/~g/ 
ml  phytohemagglutinin (PHA)  (Welleome Reagents Ltd.,  Greenville, N.  C.)  and the  other 
without  PHA as control. Each was  divided into four subgroups:  the  first  used  for  studying 
DNA  synthesis  was  incubated  with  1  ~Ci/ml  [aH]thymidine  (6.7  Ci/mM  New  England 
Nuclear); the second used for studying RNA synthesis was incubated with 1/~Ci/ml [aH]uridine 
(22.4  Ci/mM,  New  England  Nuclear);  the  third  used  for  studying  protein  synthesis  was 
incubated with 1/~Ci/ml [14C]L-amino acids (New England Nuclear; 1276-113); the fourth was 
used for making cytocentrifuged spreads. The different preparations were harvested every 2 h, 
and radioisotope incorporation was determined by scintillation counting or autoradiography as 
described above. 1904  A  NUCLEAR  ANTIGEN  ASSOCIATED  WITH  CELL  PROLIFERATION 
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FIG.  4.  Incorporation of [~H]thymidine counted  by liquid scintillation counter  ([3H]thymidine 
uptake, O-'--O),  percentage of cells  incorporating [3H]thymidine by autoradiography ([3H]thy- 
midine  labeling index, ~  - ---D),  and  percentage of cells  undergoing mitosis  (mitotic  index, 
•  ..... •)  in WiL-2 cells synchronized by double thymidine block are shown in A. When the cells 
were released from thymidine block, they proceeded rapidly into S phase.  By  10 h, mitosis had 
begun. B depicts percent of cells showing nucleolar staining with anti-PCNA serum (EBa).  In early 
S, there was high percentage of cells showing nucleolar staining, and the percentage progressively 
decreased. When the cells entered the second S phase, nucleolar staining increased again (22-24 h). 
Results 
Preparation ofMonospecific  Anti-PCNA Sera.  Because our analysis had demonstrated 
that the two sera, MN and EB, both contained other antibodies besides anti-PCNA, 
absorption  studies  were  performed  with  insolubilized  immunoadsorbant  of rabbit 
kidney extract  as described  above.  A  representative  result  of such  studies  is shown 
with EB serum. In double diffusion analysis (Fig.  1), EB serum reacted with WiL-2 
extract to produce a  strong precipitin line and a  second weaker precipitin line. The 
strong  precipitin  line  was  anti-PCNA.  In  this  figure,  MN  serum  showed  only one 
precipitin  line  (anti-PCNA)  which  identified  with  the strong precipitin  line of EB. 
The  characteristics  of the  MN  precipitin  line  that  established  that  this  was  anti° 
PCNA had been pubished previously (1).  The weak precipitin line of EB serum was 
anti-Sin  because  it  completely fused  in  immunological  identity  with  the  reference 
anti-Sm serum. After absorption with  insolubilized  rabbit kidney extract, absorbed 
serum (EBa) showed slightly weaker anti-PCNA preeipitin, but the anti-Sm precipitin 
was completely removed. In immunofluorescence studies (Table II), EB serum before 
absorption demonstrated nuclear staining of mouse kidney parenchymal cells at  1:32 
dilution  (related  to  anti-Sin  antibody)  but  after absorption  even  undiluted  serum 
showed no nuclear staining of parenchymal cells.  On  WiL-2 cells,  nuclear  staining 
titers were  1:512  before absorption and  1:64  after absorption.  The fall in  titer after 
absorption that was demonstrated both by immunofluorescence and by immunodifo 
fusion is not entirely clear. We presume that it might be related to the fact that small YOSHINARI TAKASAKI, JAU-SHYONG DENG, AND  ENG M. TAN  1905 
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F[G.  5.  Similar studies as depicted in  Figs. 2 and 4 but with  peripheral blood lymphocytes 
stimulated by PHA (A). Labeling index showing [nH]uridine  and [14C]L-amino  acid uptake rapidly 
increased and became maximum at 12 h, Labeling index for [3H]thymidine  uptake started at 26 h 
and became maximum at  54 h.  (B)  NucIeolar staining started to appear  2 h after stimulation, 
increased in parallel with the percentage of cells that  incorporated uridine and amino acid and 
reached ils peak at 12 h. It decreased before initiation of thymidine uptake. 
amounts of PCNA antigen are present in the kidney extract because previous studies 
had  demonstrated that  a  few  interstitial cells in the kidney contained PCNA.  The 
studies reported below were performed primarily with the use of absorbed EB serum 
that were confirmed at critical steps with MN serum. 
PCNA  in Synchronized WiL-2 Cells.  The results of synchronization of WiL-2 cells 
after  density-dependent arrest  are  shown  in  Fig.  2 A.  For  -8  h  after  release  from 
density-dependent arrest, >90% of the cells were in G~, where no DNA synthesis was 
taking place.  After this, DNA synthesis was documented by thymidine uptake and 
labeling index. The DNA synthetic phase (S) reached its peak by 16-18 h. Mitosis did 
not appear until 22-24 h  of culture. WiL-2 cells were examined with EB-absorbed 
serum at different phases of the synchronized cells, and the results are shown in Fig. 
3.  At  Go  (A)  immediately after  release  from  density-dependent arrest,  PCNA was 1906  A NUCLEAR  ANTIGEN  ASSOCIATED  WITH  CELL  PROLIFERATION 
Fic.  6.  Fluorescence photomicrographs  of human  peripheral  blood  lymphocytes stimulated  by 
PHA. After stimulation,  lymphocytes were stained with anti-PCNA  serum (EBa) every 2 h. From 
2-12 h after stimulation,  positive cells showed only nucleolar staining pattern (A, 2-h cells). From 
12-24 h, nuclear staining began to appear in addition to nucleolar staining (B, 94-h cells). At 60 h, 
speckled nuclear  staining  became  very strong, whereas nucleolar  staining  had disappeared  (C). 
Radiating strands  of staining  within  areas  of chromosome condensation  could  be observed  in 
addition to staining  in areas peripheral  to chromosome condensation in a mitotic celt (D, arrow) 
(x  t,2oo). 
present as speckled nucleoplasmic staining. At 12 h  (B), nucleolar staining was clearly 
evident. In many cells, nucleolar staining was present together with speckled nucleo- 
plasmic staining. At 20 h  (C), nucleolar staining had disappeared from most cells but 
speckled nucleoplasmic staining was very strong. Finally, in mitosis (D), staining was 
more intense in areas peripheral to chromosome condensation, but  radiating strands 
of staining could be seen within the region of chromosome condensation. 
The  phenomenon  of nucleolar  staining  in  the  12-h  cells  was  unexpected,  and 
further observations were made with cells harvested every 2 h. The results are plotted 
on Fig. 2 B so that they could be related to the phase of the cell cycle. It is seen that 
a  low  percentage  of cells with  nucleolar staining could  be observed  in  resting  and 
early G1 cells, but  its percentage started to increase from  6  h  (late G1)  and  the peak 
of nueleolar staining was observed at  12  h  (early S  phase). After this, the number of 
cells showing nucleolar staining declined. 
This observation of nucleolar staining in late Ga and early S was further confirmed 
on  WiL-2 cells that  were synchronized by double  thymidine block. In  Fig. 4 A, the YOSHINARI TAKASAKI, JAU-SHYONG DENG, AND ENG M. TAN  1907 
characteristics of thymidine uptake, labeling index, and mitosis of WiL-2 cells released 
from  thymidine  block  are  depicted.  After  release  from  block,  the  cells  entered 
immediately into S phase but did not reach peak DNA synthesis until 8-10 h  later. 
However, when cells with nucleolar staining were examined, the highest number of 
cells with  nucleolar staining had  reached maximum  levels within  2 h  after release 
from thymidine block (Fig. 4 B). Analogous to the findings shown in Fig. 2, cells in 
late S and G2 had a lower frequency of nucleolar staining. 
PCNA in Mitogen-stirnulated  Lyrnphocytes.  After PHA stimulation of human periph- 
eral lymphocytes, the kinetics of amino acid, uridine, and  thymidine incorporation 
are  shown  in  Fig.  5 A.  The percentage of cells  that  incorporated amino  acid  and 
uridine rapidly reached its maximum by 12 h, but thymidine incorporation did not 
commence until after 24 h  and reached its peak at 54 h. PHA-stimulated cells were 
examined with  anti-PCNA  serum.  At  2  h  after addition  of PHA,  weak nucleolar 
staining  could  be  observed  in  some  cells  (Fig.  6 A).  There  was  probably  some 
cytoplasmic staining also at this time. Before addition of PHA, none of the lympho- 
cytes showed nuclear or nucleolar staining  (not shown  in the figure). At 24 h  (Fig. 
6 B),  there  was  strong  nucleolar  staining  in  many  cells,  associated  with  speckled 
nuclear staining. The latter was most evident in the clump of agglutinated cells. At 
60 h  (Fig. 6 C), strong speckled nuclear staining was present. Nucleolar staining was 
not evident at this time.  In Fig.  6 D, a  cell that  appears to be in mitosis shows the 
same characteristics of staining, as reported previously for synchronized WiL-2 cells. 
When PHA-stimulated cells were harvested every 2 h and the frequency of nucleolar 
staining plotted  (Fig.  5 B), it was seen that  nucleolar staining increased in parallel 
with  uridine and  amino  acid  incorporation and  reached  the  peak at  12  h.  It  had 
already declined before initiation of thymidine uptake. In contrast, speckled nuclear 
staining  appeared more slowly than  nucleolar staining and  did  not  reach its peak 
until DNA synthesis. 
Discussion 
The two sera that were used for these studies both have precipitating anti-PCNA 
antibody, but each had, in addition, antibodies to other nuclear antigens. In absorp- 
tion  studies  using  insolubilized  rabbit  kidney  extract  as  the  immunoadsorbant, 
precipitating antibodies to other nuclear antigens were removed with the exception of 
anti-PCNA.  The observations that  are reported here are based on  the assumption 
that the absorbed serum recognized only PCNA antigen under the conditions of the 
experiments. There is reasonable evidence to support this assumption. In our experi- 
ence with many different autoantibody systems, only anti-PCNA has been shown to 
react  with  a  nuclear  antigen  present  in  proliferating  cells  but  undetectable  in 
differentiated  cells  of organs  such  as  kidney  and  liver.  This  experience  includes 
antibodies to DNA, histones and nonhistone nuclear antigens such as Sm, RNP, SS- 
A, SS-B, nuclear antigens associated with scleroderma such as Scl-70, and centromere 
antigen (5, 6,  11-14). In the final analysis, it would be necessary to use purified anti- 
PCNA antibody or a  monoclonal anti-PCNA antibody to confirm the observations 
reported here. Such reagents are not presently available. 
One of the striking observations concerning PCNA is its presence in the nucleolus. 
From  the observations in  an  established  cell line  (WiL-2)  and  in  PHA stimulated 
lymphocytes,  the  appearance  of  PCNA  in  the  nucleolus  appears  to  precede  its 1908  A NUCLEAR ANTIGEN ASSOCIATED WITH CELL PROLIFERATION 
subsequent  localization  in  the  nucleoplasm.  In  the  case  of  the  WiL-2  cell  line, 
nucleolar  staining  was  the  dominant  pattern  in  a  period  overlapping late G1  and 
early S. However, in PHA-stimulated lymphocytes, nucleolar staining was the domi- 
nant pattern well before DNA synthesis occurred. At the present time, we do not have 
any explanation for this apparent difference. It could be related to the fact that in the 
WiL-2  cell, a  continuously  proliferating line,  PCNA was present  at  all  times, even 
during  interphase.  In  peripheral  blood  lymphocytes,  PCNA  was  not  detected  in 
unstimulated  cells but  appeared de  novo  immediately after PHA stimulation.  These 
observations raise  questions  concerning  the  possibility that  PCNA  may play some 
regulatory role in DNA replication.  Further, biochemical characterization of PCNA 
and studies to elucidate its biological function would be of interest. 
The observation that PCNA is an antigen related to blast transformation has been 
used in some preliminary studies to determine if anti-PCNA may be a useful reagent 
for examination of neoplastic cells. In studies on patients with chronic myelogenous 
leukemia, it has been shown that anti-PCNA can detect blast crisis in this disease by 
the  demonstration  of  increased  numbers  of  PCNA-positive  blastoid  ceils  in  the 
peripheral blood. These studies are in progress in this laboratory and will be reported 
separately. 
Summary 
A  nuclear  antigen  associated  with  cell  proliferation  (proliferating  cell  nuclear 
antigen-PCNA)  and blast transformation is recognized by autoantibodies in the sera 
of some patients with systemic lupus erythematosus. This autoantibody is a  precipi- 
tating antibody and also reacts in immunofluorescence, staining the nucleoplasm of 
proliferating and blast-transformed cells. The autoantibody was used as a reagent to 
determine the distribution  of PCNA in a  synchronized continuous  B  lymphoid cell 
line (WiL-2) and in mitogen-induced blast-transformed lymphocytes. In WiL-2 cells, 
PCNA was detected as speckled nucleoplasmic staining in G1, S, and G2 phases of the 
cell cycle. In addition, during late G1 and early S phases, PCNA was also detected in 
the nucleolus.  During mitogen-induced blast transformation of lymphoyctes, PCNA 
was noticed in the nucleolus before the initiation of DNA synthesis and later became 
nucleoplasmic  with  diappearance  of nucleolar  staining.  These studies  demonstrate 
that  the  relationship  of PCNA  to  proliferation  and  blast  transformation  may  be 
associated with events related to DNA synthesis in these cells. 
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